Psychotic disorders as a framework for precision psychiatry

被引:19
|
作者
Coutts, Fiona [1 ]
Koutsouleris, Nikolaos [1 ,2 ,3 ]
McGuire, Philip [4 ,5 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[2] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany
[3] Max Planck Inst Psychiat, Munich, Germany
[4] Univ Oxford, Dept Psychiat, Oxford, England
[5] NIHR Oxford Hlth Biomed Res Ctr, Oxford, England
关键词
CLINICAL HIGH-RISK; TREATMENT-RESISTANT SCHIZOPHRENIA; ULTRA-HIGH-RISK; DOPAMINE SYNTHESIS CAPACITY; 1ST EPISODE PSYCHOSIS; FUNCTIONAL CONNECTIVITY; ANTIPSYCHOTIC TREATMENT; FOLLOW-UP; 1ST-EPISODE PSYCHOSIS; PREDICTIVE-VALIDITY;
D O I
10.1038/s41582-023-00779-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
People with psychotic disorders can show marked interindividual variations in the onset of illness, responses to treatment and relapse, but they receive broadly similar clinical care. Precision psychiatry is an approach that aims to stratify people with a given disorder according to different clinical outcomes and tailor treatment to their individual needs. At present, interindividual differences in outcomes of psychotic disorders are difficult to predict on the basis of clinical assessment alone. Therefore, current research in psychosis seeks to build models that predict outcomes by integrating clinical information with a range of biological measures. Here, we review recent progress in the application of precision psychiatry to psychotic disorders and consider the challenges associated with implementing this approach in clinical practice. In this Review, the authors discuss recent efforts to predict disease onset, treatment response and disease outcome in individuals with psychosis. They cover genetic, biological, clinical and environmental predictive factors and assess whether the variation in outcomes is attributable to differences in the pathophysiology of psychosis.
引用
收藏
页码:221 / 234
页数:14
相关论文
共 50 条
  • [31] Precision Medicine for Psychotic Disorders: Objective Assessment, Risk Prediction, Pharmacogenomics, and Repositioned Drugs
    Niculescu, Alexander
    Hill, Mariah
    MacKie, Oliver
    Bhagar, Rowan
    Roseberry, Kyle
    Dainton, Helen
    Kurian, Sunil
    Shekhar, Anantha
    Le-Niculescu, Helen
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S285 - S285
  • [32] Precision psychiatry: toward a neural circuit taxonomy for mood and emotion regulation disorders
    Williams, L.
    BIPOLAR DISORDERS, 2017, 19 : 10 - 11
  • [33] Mental disorders of known aetiology and precision medicine in psychiatry: a promising but neglected alliance
    Fraguas, D.
    Diaz-Caneja, C. M.
    State, M. W.
    O'Donovan, M. C.
    Gur, R. E.
    Arango, C.
    PSYCHOLOGICAL MEDICINE, 2017, 47 (02) : 193 - 197
  • [34] Editorial: Treatment resistance in psychotic disorders Treatment resistance in psychotic disorders
    Nath, Santanu
    Kravariti, Eugenia
    Ranjan, Rajeev
    Narasimha, Venkata Lakshmi
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [35] A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders
    Lenze, Eric J.
    Rodebaugh, Thomas L.
    Nicol, Ginger E.
    JAMA PSYCHIATRY, 2020, 77 (07) : 663 - 664
  • [36] The psychotic wavelength - A psychoanalytic perspective for psychiatry
    Symington, Neville
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2010, 2 (03): : 264 - 266
  • [37] The Psychotic Wavelength: A Psychoanalytic Perspective for Psychiatry
    Martindale, Brian
    INTERNATIONAL JOURNAL OF PSYCHOANALYSIS, 2011, 92 (01): : 240 - 245
  • [38] Precision Medicine in Psychiatry
    Williams, Leanne M.
    PSYCHIATRIC ANNALS, 2024, 54 (04) : e101 - e102
  • [39] Misunderstanding precision psychiatry
    Vieta, Eduard
    Salagre, Estela
    PSYCHOLOGICAL MEDICINE, 2021, 51 (09) : 1418 - 1419
  • [40] The prospects of precision psychiatry
    Tabb, Kathryn
    Lemoine, Mael
    THEORETICAL MEDICINE AND BIOETHICS, 2021, 42 (5-6) : 193 - 210